vs
Side-by-side financial comparison of Dexcom (DXCM) and SELECTIVE INSURANCE GROUP INC (SIGI). Click either name above to swap in a different company.
SELECTIVE INSURANCE GROUP INC is the larger business by last-quarter revenue ($1.4B vs $1.3B, roughly 1.1× Dexcom). Dexcom runs the higher net margin — 21.2% vs 7.2%, a 14.0% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 5.7%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 6.6%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Selective Insurance Group Inc. is a U.S.-based insurance holding company that provides a comprehensive portfolio of property and casualty insurance products, including personal auto, home insurance, commercial property, liability, and workers' compensation coverage. It primarily serves small and medium-sized businesses, individual consumers, and nonprofits across the U.S., distributing offerings via a network of independent insurance agents.
DXCM vs SIGI — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.4B |
| Net Profit | $267.3M | $97.7M |
| Gross Margin | 62.9% | — |
| Operating Margin | 25.6% | — |
| Net Margin | 21.2% | 7.2% |
| Revenue YoY | 21.6% | 5.7% |
| Net Profit YoY | 153.6% | -37.0% |
| EPS (diluted) | $0.67 | $1.58 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | $1.4B | ||
| Q4 25 | $1.3B | $1.4B | ||
| Q3 25 | $1.2B | $1.4B | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $1.0B | $1.3B | ||
| Q4 24 | $1.1B | $1.3B | ||
| Q3 24 | $994.2M | $1.2B | ||
| Q2 24 | $1.0B | $1.2B |
| Q1 26 | $267.3M | $97.7M | ||
| Q4 25 | $267.3M | $155.2M | ||
| Q3 25 | $283.8M | $115.3M | ||
| Q2 25 | $179.8M | $85.9M | ||
| Q1 25 | $105.4M | $109.9M | ||
| Q4 24 | $151.7M | $95.5M | ||
| Q3 24 | $134.6M | $92.3M | ||
| Q2 24 | $143.5M | $-63.3M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 14.4% | ||
| Q3 25 | 20.1% | 10.7% | ||
| Q2 25 | 18.4% | 8.2% | ||
| Q1 25 | 12.9% | 10.8% | ||
| Q4 24 | 17.0% | 9.5% | ||
| Q3 24 | 15.3% | 9.4% | ||
| Q2 24 | 15.7% | -6.7% |
| Q1 26 | 21.2% | 7.2% | ||
| Q4 25 | 21.2% | 11.4% | ||
| Q3 25 | 23.5% | 8.5% | ||
| Q2 25 | 15.5% | 6.5% | ||
| Q1 25 | 10.2% | 8.6% | ||
| Q4 24 | 13.6% | 7.6% | ||
| Q3 24 | 13.5% | 7.4% | ||
| Q2 24 | 14.3% | -5.3% |
| Q1 26 | $0.67 | $1.58 | ||
| Q4 25 | $0.67 | $2.52 | ||
| Q3 25 | $0.70 | $1.85 | ||
| Q2 25 | $0.45 | $1.36 | ||
| Q1 25 | $0.27 | $1.76 | ||
| Q4 24 | $0.37 | $1.53 | ||
| Q3 24 | $0.34 | $1.47 | ||
| Q2 24 | $0.35 | $-1.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $451.8M |
| Total DebtLower is stronger | — | $901.4M |
| Stockholders' EquityBook value | $2.7B | $3.6B |
| Total Assets | $6.3B | $15.3B |
| Debt / EquityLower = less leverage | — | 0.25× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | $451.8M | ||
| Q4 25 | $917.7M | — | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $904.9M | — | ||
| Q4 24 | $606.1M | — | ||
| Q3 24 | $621.2M | — | ||
| Q2 24 | $939.2M | — |
| Q1 26 | — | $901.4M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $507.9M | ||
| Q3 24 | — | $508.2M | ||
| Q2 24 | — | $508.8M |
| Q1 26 | $2.7B | $3.6B | ||
| Q4 25 | $2.7B | $3.6B | ||
| Q3 25 | $2.7B | $3.5B | ||
| Q2 25 | $2.6B | $3.4B | ||
| Q1 25 | $2.3B | $3.3B | ||
| Q4 24 | $2.1B | $3.1B | ||
| Q3 24 | $2.0B | $3.2B | ||
| Q2 24 | $2.4B | $2.9B |
| Q1 26 | $6.3B | $15.3B | ||
| Q4 25 | $6.3B | $15.2B | ||
| Q3 25 | $7.5B | $15.0B | ||
| Q2 25 | $7.3B | $14.5B | ||
| Q1 25 | $6.8B | $14.2B | ||
| Q4 24 | $6.5B | $13.5B | ||
| Q3 24 | $6.4B | $13.5B | ||
| Q2 24 | $6.8B | $12.6B |
| Q1 26 | — | 0.25× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.16× | ||
| Q3 24 | — | 0.16× | ||
| Q2 24 | — | 0.17× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
